The autoimmune regulator: A key toward understanding the molecular pathogenesis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

Keio Journal of Medicine

Volumn 50, Issue 4, 2001, Pages 225-239

  Meriluoto, Tanja ^a,b   Halonen, Maria ^a,b   Pelto Huikko, Markku ^c   Kangas, Hannele ^a   Korhonen, Juha ^a   Kolmer, Meelis ^a,d   Ulmanen, Ismo ^a   Eskelin, Petra ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d MediCel Ltd   (Finland)

Author keywords

AIRE; APECED; APS I; Autoimmunity; Transcriptional regulation

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL; AUTOIMMUNE POLYENDOCRINOPATHY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; MUTATION; RECESSIVE GENE; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; FEMALE; GENE EXPRESSION; GENES, RECESSIVE; HUMANS; MALE; MICE; MUTATION; POLYENDOCRINOPATHIES, AUTOIMMUNE; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS;

EID: 0035748842     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: 10.2302/kjm.50.225     Document Type: Article

References (107)

1. Ahonen P: Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet 1985; 27: 535-542
2. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J: Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. Engl J Med 1990; 322: 1829-1836
3. Betterle C, Greggio NA, Volpato M: Clinical review 93: autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1998; 83: 1049-1055
4. Myhre AG, Halonen M, Eskelin P, Ekwall O, Hedstrand H, Rorsman F, Kampe O, Husebye ES: Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clin Endocrinol (Oxf) 2001; 54: 211-217
5. Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K: Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase. Lancet 1992; 339: 770-773
6. Winqvist O, Karlsson FA, Kampe O: 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992; 339: 1559-1562
7. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kampe O: Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest 1993; 92: 2377-2385
8. Winqvist O, Gebre-Medhin G, Gustafsson J, Ritzen EM, Lundkvist O, Karlsson FA, Kampe O: Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure. J Clin Endocrinol Metab 1995; 80: 1717-1723
9. Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Rees Smith B, Furmaniak J: Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab 1996; 81: 1871-1876
10. Ahonen P, Miettinen A, Perheentupa J: Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 1987; 64: 494-500
11. Clemente MG, Obermayer-Straub P, Meloni A, Strassburg CP, Arangino V, Tukey RH, De Virgiliis S, Manns MP: Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1997; 82: 1353-1361
12. Gebre-Medhin G, Husebye ES, Gustafsson J, Winqvist O, Goksoyr A, Rorsman F, Kampe O: Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Lett 1997; 412: 439-445
13. Clemente MG, Meloni A, Obermayer-Straub P, Frau F, Manns MP, De Virgiliis S: Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology 1998; 114: 324-328
14. Ekwall O, Hedstrand H, Grimelius L, Haavik J, Perheentupa J, Gustafsson J, Husebye E, Kampe O, Rorsman F: Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 1998; 352: 279-283
15. Hedstrand H, Ekwall O, Haavik J, Landgren E, Betterle C, Perheentupa J, Gustafsson J, Husebye E, Rorsman F, Kampe O: Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochem Biophys Res Commun 2000; 267: 456-461
16. Ekwall O, Hedstrand H, Haavik J, Perheentupa J, Betterle C, Gustafsson J, Husebye E, Rorsman F, Kampe O: Pteridin-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2000; 85: 2944-2950
17. Hedstrand H, Perheentupa J, Ekwall O, Gustafsson J, Michaelsson G, Husebye E, Rorsman F, Kampe O: Antibodies against hair follicles are associated with alopecia totalis in autoimmune polyendocrine syndrome type I. J Invest Dermatol 1999; 113: 1054-1058
18. Husehye ES, Gebre-Medhin G, Tuomi T, Perheentupa J, Landin-Olsson M, Gustafsson J, Rorsman F, Kampe O: Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 1997; 82: 147-150
19. Bjork E, Velloso LA, Kampe O, Karlsson FA: GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994; 43: 161-165
20. Velloso LA, Winqvist O, Gustafsson J, Kampe O, Karlsson FA: Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I. Diabetologia 1994; 37: 61-69
21. Ahonen P, Miettinen A, Perheentupa J: Cytoplasmic islet cell antibodies in patients with autoimmune polyendocinopathy-candidosis-ectodermal dystrophy. Acta Endocrinologica 1985; 109(Suppl 270): 78
22. Tuomi T, Bjorses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A: Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 1996; 81: 1488-1494
23. Perheentupa J, Miettinen A: Autoimmune polyendocrine syndrome type 1 (APECED). In: Eisenbarth GS, eds, Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity, Austin, R.G. Landes Company, 1999; 19-40
24. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995 16; 81: 935-946
25. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD: Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 1996; 98: 1107-1113
26. Wang J, Zheng L, Lobito A, Chan FK, Dale J, Sneller M, Yao X, Puck JM, Straus SE, Lenardo MJ: Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell; 98: 47-58
27. Zlotogora J, Shapiro MS: Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 1992; 29: 824-826
28. Rosatelli MC, Meloni A, Meloni A, Devoto M, Cao A, Scott HS, Peterson P, Heino M, Krohn KJ, Nagamine K, et al: A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet 1998; 103: 428-434
29. Norio R, Nevanlinna HR, Perheentupa J: Hereditary diseases in Finland; rare flora in rare soul. Ann Clin Res 1973; 5: 109-141
30. Peltonen L, Jalanko A, Varilo T: Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999; 8: 1913-1923
31. Peltonen L: Positional cloning of disease genes: advantages of genetic isolates. Hum Hered 2000; 50: 66-75
32. Aaltonen J, Bjorses P, Sandkuijl L, Perheentupa J, Peltonen L: An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet 1994; 8: 83-87
33. Bjorses P, Aaltonen J, Vikman A, Perheentupa J, Ben-Zion G, Chiumello G, Dahl N, Heideman P, Hoorweg-Nijman JJ, Mathivon L, et al: Genetic homogeneity of autoimmune polyglandular disease type I. Am J Hum Genet 1996; 59: 879-886
34. Heiskanen M, Karhu R, Hellsten E, Peltonen L, Kallioniemi OP, Palotie A: High resolution mapping using fluorescence in situ hybridization to extended DNA fibers prepared from agarose-embedded cells. Biotechniques 1994; 17: 928-929, 932-933
35. Heiskanen M, Peltonen L, Palotif A: Visual mapping by high resolution FISH. Trends Genet 1996; 12: 379-382
36. Aaltonen J, Horelli-Kuitunen N, Fan JB, Bjorses P, Perheentupa J, Myers R, Palotie A, Peltonen L: High-resolution physical and transcriptional mapping of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy locus on chromosome 21q22.3 by FISH. Genome Res 1997; 7: 820-829
37. Korn B, Sedlacek Z, Manca A, Kioschis P, Konecki D, Lehrach H, Poustka A: A strategy for the selection of transcribed sequences in the Xq28 region. Hum Mol Genet 1992; 1: 235-242
38. Church DM, Stotler CJ, Rutter JL, Murrell JR, Trofatter JA, Buckler AJ: Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nat Genet 1994; 6: 98-105
39. Levanon D, Brandeis M, Bernstein Y, Groner Y: Common promoter features in human and mouse liver type phosphofructokinase gene. Biochem Mol Biol Int 1995; 35: 929-936
40. Uberbacher EC, Mural RJ: Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach. Proc Natl Acad Sci USA 1991; 88: 11261-11265
41. Kulp D, Haussler D, Reese MG, Eeckman FH: A generalized hidden Markov model for the recognition of human genes in DNA. Proc Int Conf Intell Syst Mol Biol 1996; 4: 134-142
42. The Finnish-German APECED Consortium: An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. The Finnish-German APECED Consortium. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Nat Genet 1997; 17: 399-403
43. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, et al: Positional cloning of the APECED gene. Nat Genet 1997; 17: 393-398
44. Mount SM: A catalogue of splice junction sequences. Nucleic Acids Res 1982; 10: 459-472
45. Aasland R, Gibson TJ, Stewart AF: The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci 1995; 20: 56-59
46. Heery DM, Kalkhoven E, Hoare S, Parker MG: A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997; 387: 733-736
47. Ren Y, Behre E, Ren Z, Zhang J, Wang Q, Fondell JD: Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors. Mol Cell Biol 2000; 20: 5433-5446
48. Webb P, Anderson CM, Valentine C, Nguyen P, Marimuthu A, West BL, Baxter JD, Kushner PJ: The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol 2000; 14: 1976-1985
49. Gibson TJ, Ramu C, Gemund C, Aasland R: The APECED polyglandular autoimmune syndrome protein. AIRE-1, contains the SAND domain and is probably a transcription factor. Trends Biochem Sci 1998; 23: 242-244
50. Sternsdorf T, Jensen K, Reich B, Will H: The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem 1999; 274: 12555-12566
51. Welsh GI, Kadereit S, Coccia EM, Hovanessian AG, Meurs EF: Colocalization within the nucleolus of two highly related IFN-induced human nuclear phosphoproteins with nucleolin. Exp Cell Res 1999; 250: 62-74
52. Michelson RJ, Collard MW, Ziemba AJ, Persinger J, Bartholomew B, Huggenvik JI: Nuclear DEAF-1-related (NUDR) protein contains a novel DNA binding domain and represses transcription of the heterogeneous nuclear ribonucleoprotein A2/B1 promoter. J Biol Chem 1999; 274: 30510-30519
53. LeBoeuf RD, Ban EM, Green MM, Stone AS, Propst SM, Blalock JE, Tauber JD: Molecular cloning, sequence analysis, expression, and tissue distribution of suppressin, a novel suppressor of cell cycle entry. J Biol Chem 1998; 273: 361-368
54. Theriault JR, Charette SJ, Lambert H, Landry J: Cloning and characterization of hGMEB1, a novel glucocorticoid modulatory element binding protein. FEBS Lett 1999; 452: 170-176
55. Mittaz L, Rossier C, Heino M, Peterson P, Krohn KJ, Gos A, Morris MA, Kudoh J, Shimizu N, Antonarakis SE, et al: Isolation and characterization of the mouse Aire gene. Biochem Biophys Res Commun 1999; 255: 483-490
56. Seeler JS, Marchio A, Sitterlin D, Transy C, Dejean A: Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci USA 1998; 95: 7316-7321
57. Pitkanen J, Doucas V, Sternsdorf T, Nakajima T, Aratani S, Jensen K, Will H, Vahamurto P, Ollila J, Vihinen M, et al: The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem 2000; 275: 16802-16809
58. Blechschmidt K, Schweiger M, Wertz K, Poulson R, Christensen HM, Rosenthal A, Lehrach H, Yaspo ML: The mouse Aire gene: comparative genomic sequencing, gene organization, and expression. Genome Res 1999; 9: 158-166
59. Wang CY, Shi JD, Davoodi-Semiromi A, She JX: Cloning of Aire, the mouse homologue of the autoimmune regulator (AIRE) gene responsible for autoimmune polyglandular syndrome type 1 (ASP1). Genomics 1999; 55: 322-326
60. Bjorses P, Pelto-Huikko M, Kaukonen J, Aaltonen J, Peltonen L, Ulmanen I: Localization of the APECED protein in distinct nuclear structures. Hum Mol Genet 1999; 8: 259-266
61. Heino M, Peterson P, Kudoh J, Nagamine K, Lagerstedt A, Ovod V, Ranki A, Rantala I, Nieminen M, Tuukkanen J, et al: Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun 1999; 257: 821-825
62. Rinderle C, Christensen HM, Schweiger S, Lehrach H, Yaspo ML: AIRE encodes a nuclear protein co-localizing with cytoskeletal filaments: altered sub-cellular distribution of mutants lacking the PHD zinc fingers. Hum Mol Genet 1999; 8: 277-290
63. Halonen M, Pelto-Huikko M, Eskelin P, Peltonen L, Ulmanen I, Kolmer M: Subcellular location and expression pattern of autoimmune regulator (Aire), the mouse orthologue for human gene defective in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED). J Histochem Cytochem 2001; 49: 197-208
64. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM: A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 1994; 76: 333-343
65. Koken MH, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N, de Jong L, Szostecki C, Calvo F, Chomienne C, et al: The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 1994; 13: 1073-1083
66. LaMorte VJ, Dyck JA, Ochs RL, Evans RM: Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc Natl Acad Sci USA 1998; 95: 4991-4996
67. Szostecki C, Krippner H, Penner E, Bautz FA: Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin Exp Immunol 1987; 68: 108-116
68. Negorev D, Ishov AM, Maul GG: Evidence for separate ND10-binding and homo-oligomerization domains of Sp100. J Cell Sci 2001; 114: 59-68
69. Bloch DB, Chiche JD, Orth D, de la Monte SM, Rosenzweig A, Bloch KD: Structural and functional heterogeneity of nuclear bodies. Mol Cell Biol 1999; 19: 4423-4430
70. Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E: Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. Oncogene 1995; 10: 2307-2314
71. Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS: PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 1994; 14: 6858-6867
72. Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC, de The H: PML induces a novel caspase-independent death process. Nat Genet 1998; 20: 259-265
73. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R, Pandolfi PP: PML is essential for multiple apoptotic pathways. Nat Genet 1998; 20: 266-272
74. Torii S, Egan DA, Evans RA, Reed JC: Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J 1999; 18: 6037-6049
75. Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, de The H: Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 1998; 72: 1043-1051
76. Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, Kathoria M, Parkinson J: The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J Virol 1998; 72: 6581-6591
77. Anton LC, Schubert U, Bacik I, Princiotta MF, Wearsch PA, Gibbs J, Day PM, Realini C, Rechsteiner MC, Bennink JR, et al: Intracellular localization of proteasomal degradation of a viral antigen. J Cell Biol 1999; 146: 113-124
78. Bjorses P, Halonen M, Palvimo JJ, Kolmer M, Aaltonen J, Ellonen P, Perheentupa J, Ulmanen I, Peltonen L: Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet 2000; 66: 378-392
79. Sternsdorf T, Jensen K, Will H: Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol 1997; 139: 1621-1634
80. Heino M, Peterson P, Sillanpaa N, Guerin S, Wu L, Anderson G, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, et al: RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur J Immunol 2000; 30: 1884-1893
81. Ruan QG, Wang CY, Shi JD, She JX: Expression and alternative splicing of the mouse autoimmune regulator gene (Aire). J Autoimmun 1999; 13: 307-313
82. Zuklys S, Balciunaite G, Agarwal A, Fasler-Kan E, Palmer E, Hollander GA: Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Immunol 2000; 165: 1976-1983
83. Hoffmann MW, Allison J, Miller JF: Tolerance induction by thymic medullary epithelium. Proc Natl Acad Sci USA 1992; 89: 2526-2530
84. Burkly LC, Degermann S, Longley J, Hagman J, Brinster RL, Lo D, Flavell RA: Clonal deletion of V beta 5+ T cells by transgenic I-E restricted to thymic medullary epithelium. J Immunol 1993; 151: 3954-3960
85. Ritter MA, Boyd R: Development in the thymus: it takes two to tango. Immunol Today 1993; 14: 462-469
86. van Ewijk W, Shores EW, Singer A: Crosstalk in the mouse thymus. Immunol Today 1994; 15: 214-217
87. Hollander GA, Wang B, Nichogiannopoulou A, Platenburg PP, van Ewijk W, Burakoff SJ, Gutierrez-Ramos JC, Terhorst C: Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes. Nature 1995; 373: 350-353
88. Naquet P, Naspetti M, Boyd R: Development, organization and function of the thymic medulla in normal, immunodeficient or autoimmune mice. Semin Immunol 1999; 11: 47-55
89. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, Tizard R, Cate R, Lo D: Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995; 373: 531-536
90. DeKoning J, DiMolfetto L, Reilly C, Wei Q, Havran WL, Lo D: Thymic cortical epithelium is sufficient for the development of mature T cells in relB-deficient mice. J Immunol 1997; 158: 2558-2566
91. Ryseck RP, Bull P, Takamiya M, Bours V, Siebenlist U, Dobrzanski P, Bravo R: RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. Mol Cell Biol 1992; 12: 674-684
92. Myhre AG, Bjorses P, Dalen A, Husebye ES: Three sisters with Addison's disease. J Clin Endocrinol Metab 1998; 83: 4204-4206
93. Pearce SH, Cheetham T, Imrie H, Vaidya B, Barnes ND, Bilous RW, Carr D, Meeran K, Shaw NJ, Smith CS, et al: A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet 1998; 63: 1675-1684
94. Scott HS, Heino M, Peterson P, Mittaz L, Lalioti MD, Betterle C, Cohen A, Seri M, Lerone M, Romeo G, et al: Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol 1998; 12: 1112-1119
95. Wang CY, Davoodi-Semiromi A, Huang W, Connor E, Shi JD, She JX: Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Hum Genet 1998; 103: 681-685
96. Heino M, Scott HS, Chen Q, Peterson P, Maebpaa U, Papasavvas MP, Mittaz L, Barras C, Rossier C, Chrousos GP, et al: Mutation analyses of North American APS-1 patients. Hum Mutat 1999; 13: 69-74
97. Ward L, Paquette J, Seidman E, Huot C, Alvarez F, Crock P, Delvin E, Kampe O, Deal C: Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab 1999; 84: 844-852
98. Ishii T, Suzuki Y, Ando N, Matsuo N, Ogata T: Novel mutations of the autoimmune regulator gene in two siblings with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2000; 85: 2922-2926
99. Saugier-Veber P, Drouot N, Wolf LM, Kuhn JM, Frehourg T, Lefebvre H: Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Eur J Endocrinol 2001; 144: 347-351
100. Youssoufian H, Kazazian HH Jr, Phillips DG, Aronis S, Tsiftis G, Brown VA, Antonarakis SE: Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. Nature 1986; 324: 380-382
101. Fukuhara Y, Sakuraba H, Oshima A, Shimmoto M, Nagao Y, Nadaoka Y, Suzuki T, Suzuki Y: Partial deletion of human alpha-galactosidase A gene in Fabry disease: direct repeat sequences as a possible cause of slipped mispairing. Biochem Biophys Res Commun 1990; 170: 296-300
102. Frischmeyer PA, Dietz HC: Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 1999; 8: 1893-1900
103. Mackay IR: Science, medicine, and the future: Tolerance and autoimmunity. BMJ 2000; 321: 93-96
104. Ekwall O: Pteridine Dependent Hydroxylases as Autoantigens in Autoimmune Polyendocrine Syndrome Type 1, Uppsala, Acta Universitatis Upsaliensis, 2001
105. Li Y, Song YH, Rais N, Connor E, Schatz D, Muir A, Maclaren N: Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996; 97: 910-914
106. Gylling M, Tuomi T, Bjorses P, Kontiainen S, Partanen J, Christie MR, Knip M, Perheentupa J, Miettinen A: ss-cell autoantibodies, human leukocyte antigen II alleles, and type I diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2000; 85: 4434-4440
107. Karlsson FA, Burman P, Loof L, Mardh S: Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach. J Clin Invest 1988; 81: 475-459